Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0WO8A
|
||||
Former ID |
DNC006100
|
||||
Drug Name |
1,3,5-tris(4-chlorophenyl)imidazolidine-2,4-dione
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527995] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H13Cl3N2O2
|
||||
Canonical SMILES |
C1=CC(=CC=C1C2C(=O)N(C(=O)N2C3=CC=C(C=C3)Cl)C4=CC=C(C=C<br />4)Cl)Cl
|
||||
InChI |
1S/C21H13Cl3N2O2/c22-14-3-1-13(2-4-14)19-20(27)26(18-11-7-16(24)8-12-18)21(28)25(19)17-9-5-15(23)6-10-17/h1-12,19H
|
||||
InChIKey |
CUKPDQSSXDAABM-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 1 | Target Info | Inhibitor | [527995] | |
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.